Zantac and Generic Ranitidine
Zantac and generic forms of ranitidine have been sold to Canadians for many years as both over-the-counter and prescription drugs to treat heartburn, acid reflux, and other gastrointestinal conditions.
However, either during digestion or over the course of the product’s shelf life, ranitidine can break down into what Health Canada classifies as a probable human carcinogen: N-nitrosodimethylamine (NDMA).
If you have ingested Zantac or ranitidine, you may have been exposed to NDMA levels many thousands of times greater than what Health Canada and the Food and Drug Administration considers an acceptable daily limit.
Health Canada has recalled ranitidine products and will no longer permit the distribution of ranitidine products throughout the country.
Ranitidine products have been marketed in Canada for several decades without any warning of a potential to cause cancer.
Preszler Injury Lawyers is currently conducting a mass tort campaign for people who believe they developed cancer as a result of taking Zantac or generic ranitidine. If the use of ranitidine products caused you to develop cancer, you may be entitled to compensation. Our Ontario personal injury lawyers may be able to represent your best interest in a mass tort.
Mass tort lawsuits involve numerous plaintiffs taking legal action against a single defendant, generally a large company or organization, such as the manufacturer of a dangerous drug.
Furthermore, if one of your immediate family members died of the cancer they developed as the result of using ranitidine products, our Ontario wrongful death lawyers may be able to help you recover compensation for damages you have incurred as a result of their untimely passing.
For more information on products that have been recalled by Health Canada due to a nitrosamine impurity, click here.
Please ensure that all medication boxes, labels, and receipts related to the medication are kept in a safe place if they are still available to you.